Skip to main content
Top

Advances in Therapy

Issue 9/2024

Content (19 Articles)

Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review

Fernando Gómez-Peralta, Isabel Leiva-Gea, Natalia Duque, Esther Artime, Miriam Rubio de Santos

Psychological Factors Related to Treatment Outcomes in Head and Neck Cancer

Antti A. Mäkitie, Rasheed Omobolaji Alabi, Laura Pulkki-Råback, Alhadi Almangush, Jonathan J. Beitler, Nabil F. Saba, Primož Strojan, Robert Takes, Orlando Guntinas-Lichius, Alfio Ferlito

A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients

  • Open Access
  • NSCLC
  • Original Research

Akito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba

A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese Patients

  • Open Access
  • SCLC
  • Original Research

Motohiro Tamiya, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima, Yasutaka Chiba

Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study

Guoying Cao, Haijing Yang, Jingjing Wang, Masahiro Ishida, Christian Thoma, Thomas Haeufel, Sebastian Bossert, Jing Zhang

Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain

Manuel Botana López, Miguel Camafort Babkowski, Raquel Campuzano Ruiz, Ana Cebrián Cuenca, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio de Santos

Real-World Treatment Patterns and Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease in Japan: The REMIND Study

Yasuhiro Gon, Ryoko Sorimachi, Yuri Yoshida, Yoichi Tamai, Ikumi Takashima, Yoshifumi Arita, Hisatoshi Sugiura

Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map

Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M. Turner, Janvi Sah

Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study)

Tobias J. Lange, Pilar Escribano-Subias, Audrey Muller, Catarina C. Fernandes, Martina Fontana, Tatiana Remenova, Stefan Söderberg, Sean Gaine

Validation of an AI-Powered Automated X-ray Bone Age Analyzer in Chinese Children and Adolescents: A Comparison with the Tanner–Whitehouse 3 Method

Yan Liang, Xiaobo Chen, Rongxiu Zheng, Xinran Cheng, Zhe Su, Xiumin Wang, Hongwei Du, Min Zhu, Guimei Li, Yan Zhong, Shengquan Cheng, Baosheng Yu, Yu Yang, Ruimin Chen, Lanwei Cui, Hui Yao, Qiang Gu, Chunxiu Gong, Zhang Jun, Xiaoyan Huang, Deyun Liu, Xueqin Yan, Haiyan Wei, Yuwen Li, Huifeng Zhang, Yanjie Liu, Fengyun Wang, Gaixiu Zhang, Xin Fan, Hongmei Dai, Xiaoping Luo

Content Validity and Psychometric Evaluation of the Crohn’s Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn’s Disease

Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly, Sarah Ollis, Emma Pranschke, Kristina Fitzgerald, Ana Paula Lacerda, Ezequiel Neimark, Yuri Sanchez Gonzalez, Julian Panés

Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2

Claire N. Harrison, Alessandro M. Vannucchi, Christian Recher, Francesco Passamonti, Aaron T. Gerds, Juan Carlos Hernandez-Boluda, Abdulraheem Yacoub, Shireen Sirhan, Catherine Ellis, Bharat Patel, Bryan Strouse, Uwe Platzbecker

Correction to: Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy

LeighAnn Y. Vincik, Alexandra D. Dautel, Abigail A. Staples, Lillian V. Lauck, Catherine J. Armstrong, Jeffery T. Howard, David McGregor, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D. Kaye

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar